SE8401538L - Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande koffein och forfaranden for anvendning av dessa - Google Patents

Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande koffein och forfaranden for anvendning av dessa

Info

Publication number
SE8401538L
SE8401538L SE8401538A SE8401538A SE8401538L SE 8401538 L SE8401538 L SE 8401538L SE 8401538 A SE8401538 A SE 8401538A SE 8401538 A SE8401538 A SE 8401538A SE 8401538 L SE8401538 L SE 8401538L
Authority
SE
Sweden
Prior art keywords
analgetic
procedures
improved
analgesic
compositions including
Prior art date
Application number
SE8401538A
Other languages
English (en)
Other versions
SE466481B (sv
SE8401538D0 (sv
Inventor
A Sunshine
E M Laska
C E Siegel
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of SE8401538L publication Critical patent/SE8401538L/sv
Publication of SE8401538D0 publication Critical patent/SE8401538D0/sv
Publication of SE466481B publication Critical patent/SE466481B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SE8401538A 1982-07-22 1984-03-20 Analgetiska och anti-inflammatoriska kompositioner innefattande koffein SE466481B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22
PCT/US1983/001121 WO1984000488A1 (en) 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Publications (3)

Publication Number Publication Date
SE8401538L true SE8401538L (sv) 1984-03-20
SE8401538D0 SE8401538D0 (sv) 1984-03-20
SE466481B SE466481B (sv) 1992-02-24

Family

ID=23584242

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401538A SE466481B (sv) 1982-07-22 1984-03-20 Analgetiska och anti-inflammatoriska kompositioner innefattande koffein

Country Status (15)

Country Link
JP (3) JPS59501459A (sv)
AT (2) AT389226B (sv)
AU (1) AU558485B2 (sv)
BE (1) BE897356A (sv)
CA (1) CA1217429A (sv)
CH (1) CH659391A5 (sv)
DE (1) DE3390116C2 (sv)
FR (1) FR2530469A1 (sv)
GB (1) GB2134786B (sv)
IE (1) IE55367B1 (sv)
IT (1) IT1206502B (sv)
NL (1) NL191432C (sv)
SE (1) SE466481B (sv)
WO (1) WO1984000488A1 (sv)
ZA (2) ZA835324B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
CH669523A5 (sv) * 1986-06-25 1989-03-31 Mepha Ag
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
BR0210855A (pt) 2001-07-06 2006-10-24 Penwest Pharmaceuticals Compan Método de fabricação de formulações de liberação prolongada
US9820982B2 (en) 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
JP2006282644A (ja) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd 疲労回復剤
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
JP7523879B2 (ja) * 2016-10-31 2024-07-29 エスエス製薬株式会社 医薬組成物
JP2021054728A (ja) * 2019-09-27 2021-04-08 興和株式会社 医薬品
JP6811453B1 (ja) * 2020-06-24 2021-01-13 医療法人すぎやま内科 経皮吸収用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS54154416A (en) * 1978-05-26 1979-12-05 Tdk Electronics Co Ltd High dielectric constant porcelain composition
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use

Also Published As

Publication number Publication date
DE3390116T1 (de) 1985-01-10
AU1881683A (en) 1984-02-23
AT389998B (de) 1990-02-26
IE831715L (en) 1984-01-22
AU558485B2 (en) 1987-01-29
SE466481B (sv) 1992-02-24
JPS59501460A (ja) 1984-08-16
ZA835324B (en) 1984-09-26
ZA835326B (en) 1984-09-26
AT389226B (de) 1989-11-10
ATA903983A (de) 1989-04-15
NL8320240A (nl) 1984-06-01
GB8406704D0 (en) 1984-04-18
IT8322173A0 (it) 1983-07-21
FR2530469A1 (fr) 1984-01-27
BE897356A (fr) 1983-11-14
IE55367B1 (en) 1990-08-29
NL191432B (nl) 1995-03-01
NL191432C (nl) 1995-07-04
ATA245988A (de) 1989-08-15
CH659391A5 (de) 1987-01-30
JPH07165583A (ja) 1995-06-27
GB2134786B (en) 1986-05-08
IT1206502B (it) 1989-04-27
GB2134786A (en) 1984-08-22
CA1217429A (en) 1987-02-03
WO1984000488A1 (en) 1984-02-16
SE8401538D0 (sv) 1984-03-20
JPS59501459A (ja) 1984-08-16
DE3390116C2 (de) 1994-06-16

Similar Documents

Publication Publication Date Title
SE8503762D0 (sv) Analgetiska och anti-inflammatoriska kompositioner innefattande xantiner och forfarande for anvendning av dessa
IT1206501B (it) Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina.
SE8401538D0 (sv) Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande koffein och forfaranden for anvendning av dessa
ES548168A0 (es) Procedimiento para preparar composiciones de uso cosmetico o farmaceutico a base de unas esferulas lipidicas que contienen un polimero de poliamida.
DK372786A (da) Farmaceutiske praeparater af phenindamin (2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridin)
DE3750431D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE3586545D1 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
ATE22007T1 (de) Pharmazeutische mischung.
SE8401537L (sv) Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande ibuprofen och sett att anvenda dessa
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
MX9102500A (es) Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DE3382086D1 (de) Pharmazeutische mixtur.
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
DE3382112D1 (de) Pharmazeutische zusammensetzung.
DE3784595D1 (de) Arzneimittel gegen feste tumoren.
ATE74757T1 (de) Phenol enthaltende, fluessige antitussivzusammensetzungen.
ES490453A0 (es) Un procedimiento para la preparacion de una composicion far-maceutica de quinazolinonas analgesicas
NO801759L (no) Farmasoeytisk tilberedning for oral administrasjon samt fremgangsmaate for fremstilling av tilberedningen
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
IT8219216A0 (it) Ne e relative composizioni farmaceu composto ad attivita' antiinfiammatiche toria,analgesica e mucoregolatrice, procedimento per la sua preparazio-
IT8721998A0 (it) Procedimento e dispositivo per la guida stabilizzata di una superficie di scorrimento materiali in movimento.
NL170855B (nl) Geneesmiddelen met werking tegen atheroma en de daarin voorkomende pyrimidinederivaten.
SE8504612D0 (sv) Analgetiska och antiinflammatoriska kompositioner innefattande difenhydramin och forfaranden for anvendning av dessa
ZA835760B (en) 2-substituted 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-beta-carbolines,their preparation and their use as drugs

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8401538-7

Format of ref document f/p: F

NUG Patent has lapsed